Aurora Cannabis Inc.

NASDAQ:ACB

Drug Manufacturers - Specialty & Generic

Healthcare
$4.40 +0.51%

+$0.02 today

Market cap
$289.28M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $2.73High $6.67

Volume 0.92M

Average 1.00M

ACB Other Investing Activities

Investing cash flows not reported separately.

Aurora Cannabis Inc.NASDAQ: ACB

Other Investing Activities · Q4 FY2026 · quarter ended Mar 2026

Other investing activities turns positive

Q4 FY2026 other investing activities was CA$235.61K, compared with -CA$3.99M a year earlier. Trailing-twelve-month other investing activities was -CA$49.69M. Over 3 fiscal years it compounded at +145.1% a year.

Context

  • Other investing activities amounted to 0.1% of revenue in FY2026, down 0.2 pp from a year earlier.
  • Other investing activities increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly other investing activities holds near CA$235.61K or moves back toward the trailing-twelve-month quarterly average of -CA$12.42M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$235.61K+100.5% QoQ
Last fiscal yearMar 2026
CA$235.61K+124.6% YoY
LTMMar 2026
-CA$49.69M+2682.4% YoY
Other Investing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+105.9%——
1 year+124.6%——
3-year CAGR+145.1%——
5-year CAGR——
10-year CAGR——

Other Investing Activities history

CAD · from the cash flow

Latest · FY2026
235.61K CAD
Year-over-year change
+124.6%
4-year CAGR
-66.8%

Other Investing Activities vs competitors

How ACB compares with its peers on the latest reported figures

  • Peers report in different currencies, so other investing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +2682.4% is the highest of 7, against a peer median of +13.4%.
  • Other investing activities amounts to 16.0% of revenue for ACB, versus a peer median of 0.0%.
ACB Competitors
Other Investing Activities for ACB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACBAurora Cannabis Inc.LTM Mar 2026CA$49.69M CAD+2682.4%+145.1%16.0%
HITIHigh Tide Inc.LTM Apr 2026CA$12.68M CAD+1498.9%-45.6%1.9%
CGCCanopy Growth CorporationLTM Mar 2026CA$8.92M CAD-81.8%+83.7%2.9%
LFMDLifeMD, Inc.LTM Mar 2026$8.09M USD+175.1%—3.7%
OGIOrganigram Global Inc.LTM Mar 2026CA$3.75M CAD-73.1%—1.4%
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 2026$4K USD——0.0%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$0 USD+100.0%—0.0%
TKNOAlpha Teknova, Inc.LTM Mar 2026$0 USD-100.0%—0.0%
EDITEditas Medicine, Inc.LTM Mar 2026$0 USD——0.0%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$0 USD——0.0%
BIOABioAge Labs, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding ACB) —+13.4%+19.1%0.0%

Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income(1.72B)(265.33M)(57.08M)15.76M(58.77M)
Depreciation & Amortization93.66M43.57M32.78M22.55M14.23M
Deferred Income Tax(2.19M)(18.4M)(1.67M)(3.19M)55.14K
Stock-Based Compensation13.76M16.89M12.72M11.52M7.29M
Change in Working Capital52.65M(25.12M)(15.54M)10.21M(9.24M)
Accounts Receivables18.34M5.53M(4.5M)5.24M(8.17M)
Inventory21.07M49.03M3.87M(15.05M)65.93M
Accounts Payables6.77M(8.06M)(15.7M)14.91M(8.06M)
Other Working Capital6.48M(71.61M)790K5.11M(58.93M)
Other Non-Cash Items1.45B190.11M(39.71M)(40.85M)40.18M
Operating Cash Flow(110.27M)(115.82M)(68.51M)16.01M(13.55M)
Capital Expenditures(32.21M)(12.13M)(16.83M)(18.86M)(22.6M)
Acquisitions (Net)(23.42M)(18.54M)(5.55M)01.1M
Purchases of Investments0000(52.35M)
Sales of Investments03.36M4.99M5.49M0
Other Investing Activities19.46M16K14.02M(956K)235.61K
Investing Cash Flow(36.17M)(27.29M)(3.36M)(14.33M)(73.62M)
Debt Repayment(170.83M)—(85.37M)(805K)(5.02M)
Common Stock Issued350.19M73.19M37.92M820K9.94M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(31.58M)(95.21M)(475K)(131K)(154.4K)
Financing Cash Flow147.78M(56.48M)(47.92M)(116K)9.79M
Effect of Forex Changes15.01M15.54M297K264K10.56M
Net Change in Cash16.35M(140.01M)(119.5M)1.83M(66.81M)
Free Cash Flow(142.48M)(127.95M)(85.34M)(2.85M)(36.15M)

Aurora Cannabis Inc.

NASDAQ:ACB

Intrinsic Alpha fair value

Locked

Current Price

$4.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.